AI Insight: Boston Scientific's current price at $48.43 is materially below the PERT-weighted fair value of $81.11, implying substantial upside potential with high confidence. Monte Carlo analysis reveals significant value volatility, with a wide range ($33.34-$2,819.03) and moderate downside risk (17.6%). Financial health scores indicate solid liquidity and leverage, though growth is modest, reflecting balanced risk with growth limitations.